Skip to Main Content

Try STAT+ TODAY

pharmalittle

Most Read

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Amazon adds $5 monthly generic drug subscription; PhRMA ends lobbying contract with brother of White House official

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Obesity guidelines cause backlash; Bayer is pushed to spin off its consumer health business

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA rejects Lilly application for Alzheimer’s drug; Sanofi offers a warranty for a medicine

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: India regulator finds 5% of drug samples are substandard; EMA claims new clinical trial registry is fixed

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Lilly and AbbVie exit U.K. drug-pricing program; J&J scales back Covid-19 vaccine production

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: HHS readying details for Medicare drug-price negotiations; doctors urge FDA to hold expert meeting before approving Alzheimer’s drug

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA increasingly pausing trials of experimental meds; FDA commish isn’t surprised by congressional report on Alzheimer’s drug

All Coverage

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pfizer is scolded by U.K. industry group over CEO’s remarks on vaccination; Amgen to lay off 300 U.S. employees

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Some Republicans push to probe Pfizer over Covid-19 ‘mutations’; Warren urges FTC to probe pharma mergers

advertisement

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Strange bedfellows lobby for Medicare coverage of obesity drugs; FDA working with WHO to probe cough syrups

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Merck ends late-stage trial for Keytruda in prostate cancer; doctor group says 60 Minutes segment on Wegovy was an ad

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: HIV vaccine study is stopped early; Merck has a plan to combat carcinogen found in diabetes drugs

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pharma prioritizes biologics over pills due to drug-pricing law; former Takeda employee accused of creating fake consulting firm

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pediatricians recommend obesity drugs for children; as JPM starts, industry execs have a gloomy financing outlook

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pfizer scaling back early-stage research into rare diseases; BioNTech and U.K. partner on cancer trials

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: New report gives glimpse into safety of an Alzheimer’s drug; Walgreens looks to dispense an abortion pill

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA rule change allows pharmacies to offer abortion pills; Medicare could have saved billions if inflationary rebate law existed

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pharma plans to raise U.S. drug prices in January; U.S. sues AmerisourceBergen over opioid crisis

Pharmalot Adam Feuerstein

STAT Plus: Pharmalittle: FDA approves a Genentech blood-cancer drug; Sean Parker expands his immunotherapy research empire

Pharmalot Matthew Herper

STAT Plus: Pharmalittle: Merck pays Chinese biotech $175 million for cancer drugs; who will make a gene therapy for very sick kids?

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: ICER cuts cost-effective price for Pfizer Covid pill; McDonald’s sets targets to reduce antibiotic use in cattle

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pharma wins changes in bill concerning accelerated approval; pharmacy chains restrict purchases of pediatric pain relievers

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA adds Lilly diabetes drugs to shortage list; WTO delays decision on extending Covid IP waiver

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: AbbVie leaves pharma industry trade groups; net drug prices see big drop after inflation

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: U.S. prisons refuse to test and treat hepatitis C patients; HHS urges Supreme Court to reject Pfizer argument on Medicare kickbacks

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Lawmakers accuse Pfizer of ‘pure greed’ over Covid vaccine price hike; Takeda to spend $4 billion on experimental pill

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Moderna and Merck vaccine lowers risk of skin cancer relapse; Cambodia halts exports of primates used for drug research

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Amgen agrees to pay $27.8 billion for Horizon Therapeutics; Roche pharma head steps down

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Medicare willing to reevaluate coverage of Alzheimer’s drugs; judge tosses shingles-vaccine lawsuits against Merck

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Mark Cuban’s drug company goes after employer market; FDA slaps import alert on key Sun Pharma plant

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Zantac lawsuits tossed over inadequate scientific evidence; Lilly tightens access to diabetes drug used for weight loss

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA fast tracks OTC version of Narcan; Express Scripts to keep Humira on its formulary but add biosimilars